Skip To Content

Table Of Contents 

Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site

2000 National Survey on Drug Use & Health

Chapter 5. Trends In Initiation of Substance Use

Estimates of substance use incidence, or initiation (i.e., number of new users during a given year), provide another measure of the Nation's substance use problem. They can suggest emerging patterns of use, particularly among young people. In the past, increases and decreases in incidence have usually been followed by corresponding changes in the prevalence of use, particularly among youths.

The incidence estimates in this report are based on combined 1999 and 2000 CAI data and should not be compared to previously published data based on PAPI data. Not only is the mode of data collection different for the incidence estimates prior to the 1999 NHSDA, but the estimation methodology has been revised as well. The estimation methodology is described in Appendix B and summarized below.

The incidence estimates are based on the NHSDA questions on age at first use, year and month of first use for recent initiates, the respondent's date of birth, and the interview date. Using this information along with editing and imputation when necessary, an exact date of first use is determined for each substance used by each respondent. For age-specific incidence rates, the period of exposure was defined for each respondent and age group for the time that the respondent was in the age group during the calendar year. Incidents of first use were also classified by year of occurrence and age at the date of first use. By applying sample weights to incidents of first use, estimates of the number of new users of each substance for each year were made. These estimates include new users at any age (including ages under 12) and are also shown for two specific age groups (12 to 17 and 18 to 25). In addition, the average age of new users in each year and age-specific rates of first use were estimated. These rates are presented in this report as the number of new users per 1,000 potential new users, since they indicate the rate of new use among persons who have not yet used the substance (i.e., potential new users). More precisely, the rates are actually the number of new users per 1,000 person-years of exposure. The numerator of each rate is the number of persons in the age group who first used the substance in the year, while the denominator is the person-time exposure measured in thousands of years. Each person's exposure time ends on the date of first use. For age-specific estimates, exposure is limited to time during the year that the person was in the age group. Persons who first used the substance in a prior year have zero exposure to first use in the current year, and persons who still have never used the substance by the end of the current year had one full year of exposure to risk.

The incidence estimates are based on retrospective reports of age at first substance use by survey respondents interviewed during 1999 and 2000, and may therefore be subject to several biases, including bias due to differential mortality of users and nonusers of each substance, bias due to memory errors (recall decay and telescoping), and underreporting bias due to social acceptability and fear of disclosure. See Appendix B for a discussion of these biases. As is explained in Appendix B, it is possible that some of these biases, particularly telescoping and underreporting because of fear of disclosure, may be affecting estimates for the most recent years more significantly. To account for this bias in the interpretation of the trends, a more stringent standard for determining statistical significance involving estimates from the most recent years (1997 and later) is used in this chapter. Differences are reported to be statistically significant only if they differ at the "=.01 level. The usual standard in the rest of the report is the "=.05 level. This is an arbitrary standard that provides some protection against incorrect conclusions in the face of potential biases that can fluctuate and even change direction from year to year. Some tentative analysis of this problem is discussed in Appendix B. A more thorough analysis of the problem using the data from 1999 to 2001 will be conducted next year.

Because the incidence estimates are based on retrospective reports of age at first use, the most recent year available for these estimates is 1999, based on the 2000 NHSDA. Estimates for the year 1999 are based only on data from the 2000 survey, while estimates for earlier years are based on the combined 1999 and 2000 data. For two of the measures, first alcohol use and first cigarette use, initiation before age 12 is common. A two-year lag in reporting of estimates is applied for these measures, because the NHSDA sample does not cover youths under age 12. The two-year lag insures that initiation at age 10 and 11 is captured in the estimation.

Marijuana

Cocaine

Heroin

Hallucinogens

Inhalants

Psychotherapeutics

Alcohol

Cigarettes

Smokeless Tobacco

Cigars

    Table of Contents

This is the page footer.

This page was last updated on June 03, 2008.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS